An elevation of plasma total SOD activities and GSH levels as well as protein expressions of MnSOD and GCLC in nonneoplastic tissues of BCC patients may indicate an adaptive response to oxidative stress. The gene discussed is SOD2; the disease is skin basal cell carcinoma.